In a human trial treating clear cell renal cell carcinoma (ccRCC), HIF-2α was inhibited successfully by PT2385 albeit non-selectively in non-tumor tissue and ccRCC metastatic tumors [129]. Here, EPAS1 is linked to neoplasm.